|
US5952294A
(en)
|
1996-07-31 |
1999-09-14 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptidyl prodrugs and methods of making and using the same
|
|
AU9797998A
(en)
|
1997-10-10 |
1999-05-03 |
Trustees Of The University Of Pennsylvania, The |
Compositions and methods for inhibiting arginase activity
|
|
BR0210149A
(pt)
|
2001-05-09 |
2004-06-29 |
Newbiotics Inc |
Pródrogas ativadas por deformilase de peptìdeo
|
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
|
JP5238936B2
(ja)
|
2005-03-25 |
2013-07-17 |
ジーアイティーアール，インク． |
Ｇｉｔｒ結合分子およびその使用
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
US8106215B2
(en)
|
2007-07-03 |
2012-01-31 |
Actelion Pharmaceuticals Ltd. |
3-aza-bicyclo[3.3.0]octane compounds
|
|
PT2175884T
(pt)
|
2007-07-12 |
2016-09-21 |
Gitr Inc |
Terapias de combinação empregando moléculas de ligação a gitr
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
US20110065633A1
(en)
|
2008-01-30 |
2011-03-17 |
Indiana University Research And Technology Corporation |
Ester-based peptide prodrugs
|
|
SI2318419T2
(sl)
|
2008-06-17 |
2025-10-30 |
Takeda Pharmaceutical Company Limited |
Spojine boronat estra in njihovi farmacevtski sestavki
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
CN102292319A
(zh)
|
2008-11-26 |
2011-12-21 |
雅培制药有限公司 |
作为钙通道阻滞剂的取代八氢环戊二烯并(c)吡咯-4-胺
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
RU2488390C2
(ru)
|
2008-12-29 |
2013-07-27 |
Тартуский Университет |
Ингибиторы аргиназы для лечения депрессии
|
|
WO2010085797A2
(en)
|
2009-01-26 |
2010-07-29 |
The Trustees Of University Of Pennsylvania |
Arginase inhibitors and methods of use
|
|
IN2015DN02826A
(enExample)
|
2009-09-03 |
2015-09-11 |
Merck Sharp & Dohme |
|
|
DK2510010T3
(en)
|
2009-12-10 |
2015-12-14 |
Hoffmann La Roche |
Antibodies that bind to human CSF1R extracellular domain 4 and their use
|
|
RU2617971C2
(ru)
|
2010-03-05 |
2017-04-28 |
Ф.Хоффманн-Ля Рош Аг |
Антитела против csf-1r человека и их применение
|
|
CN102918061B
(zh)
|
2010-03-05 |
2016-06-08 |
霍夫曼-拉罗奇有限公司 |
针对人csf-1r的抗体及其用途
|
|
EP2560978B1
(en)
|
2010-04-22 |
2019-01-30 |
Mars, Incorporated |
Inhibitors of arginase and their therapeutic applications
|
|
EP3943154A1
(en)
|
2010-05-04 |
2022-01-26 |
Five Prime Therapeutics, Inc. |
Antibodies that bind csf1r
|
|
NZ729044A
(en)
|
2010-09-09 |
2020-07-31 |
Pfizer |
4-1bb binding molecules
|
|
EP3034509B1
(en)
|
2010-10-26 |
2020-04-22 |
Mars, Incorporated |
Arginase inhibitors as therapeutics
|
|
RU2019121905A
(ru)
|
2010-12-31 |
2019-09-03 |
Астразенека Юкей Лимитед |
Ингибиторы аргиназы и способы их применения
|
|
CA2833636A1
(en)
|
2011-04-20 |
2012-10-26 |
Amplimmune, Inc. |
Antibodies and other molecules that bind b7-h1 and pd-1
|
|
CA2852685C
(en)
|
2011-10-19 |
2019-02-26 |
Mars, Incorporated |
Inhibitors of arginase and their therapeutic application
|
|
BR112014012819B1
(pt)
|
2011-11-28 |
2022-08-16 |
Merck Patent Gmbh |
Anticorpo anti-pd-l1 ou fragmento de ligação ao antígeno do mesmo e composição
|
|
MX356337B
(es)
|
2011-12-15 |
2018-05-23 |
Hoffmann La Roche |
Anticuerpos contra csf-1r humano y sus usos.
|
|
MX2014008961A
(es)
|
2012-02-06 |
2014-10-14 |
Genentech Inc |
Composiciones y metodos para utilizar inhibidores de csf1r.
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
CN104540836B
(zh)
|
2012-04-18 |
2016-11-09 |
马尔斯公司 |
作为精氨酸酶抑制剂的环约束类似物
|
|
KR20150018533A
(ko)
|
2012-05-11 |
2015-02-23 |
파이브 프라임 테라퓨틱스, 인크. |
콜로니 자극 인자 1 수용체(csf1r)에 결속하는 항체들에 의한 질병 상태의 치료 방법
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
WO2014007831A1
(en)
|
2012-07-06 |
2014-01-09 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
CN107759690A
(zh)
|
2012-08-31 |
2018-03-06 |
戊瑞治疗有限公司 |
用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法
|
|
EP3008051A4
(en)
|
2013-06-12 |
2017-03-01 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
US9663491B2
(en)
|
2014-04-15 |
2017-05-30 |
Dow Agrosciences Llc |
Metalloenzyme inhibitor compounds as fungicides
|
|
CL2014002403A1
(es)
|
2014-09-11 |
2015-01-09 |
Univ Pontificia Catolica Chile |
Metodo para la preparacion enantioselectiva y purificacion del acido 2(s)-amino-6-boronohexanoico (abh) a partir de la disolucion de bpb-ni-gly en tetrahidrofurano, neutralizacion y posterior extraccion con diclorometano, disolucion en un alcohol c1-c5, enfriamiento para lograr la precipitacion de bpb, obtencion de abh y su posterior purificacion.
|
|
JO3579B1
(ar)
|
2014-09-26 |
2020-07-05 |
Luc Therapeutics Inc |
مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
|
|
WO2016100555A1
(en)
|
2014-12-18 |
2016-06-23 |
Inception 4, Inc. |
Boronic acid derivatives and uses thereof
|
|
PL410665A1
(pl)
|
2014-12-29 |
2016-07-04 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Inhibitory arginazy oraz ich zastosowania terapeutyczne
|
|
AU2016281620B2
(en)
|
2015-06-23 |
2021-07-22 |
Calithera Biosciences, Inc. |
Compositions and methods for inhibiting arginase activity
|
|
DK3368541T3
(da)
|
2015-10-30 |
2020-06-29 |
Calithera Biosciences Inc |
Sammensætninger og metoder til inhibiering af arginaseaktivitet
|
|
PL417066A1
(pl)
*
|
2016-05-04 |
2017-11-06 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Inhibitory arginazy oraz ich zastosowania terapeutyczne
|
|
US11291674B2
(en)
|
2016-11-08 |
2022-04-05 |
Calithera Biosciences, Inc. |
Arginase inhibitor combination therapies
|
|
WO2019173182A1
(en)
|
2018-03-05 |
2019-09-12 |
Bristol-Myers Squibb Company |
Phenylpyrrolidinone formyl peptide 2 receptor agonists
|
|
EP3810615B1
(en)
|
2018-06-20 |
2026-01-28 |
Merck Sharp & Dohme LLC |
Arginase inhibitors and methods of use
|